Safety and efficacy of patients with high risk and elevated minimal residual disease after allogeneic hematopoietic stem cell transplantation treated with interferon in combination with interleukin-2 regimen.
10.3760/cma.j.issn.0253-2727.2019.03.015
- Author:
Hao AI
1
;
Yue Wen FU
;
Qian WANG
;
Xu Dong WEI
;
Yong Ping SONG
Author Information
1. Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
- Publication Type:Journal Article
- From:
Chinese Journal of Hematology
2019;40(3):238-242
- CountryChina
- Language:Chinese
